South Korea, Covıd-19, Coronavirus, Vaccine

South Korea, Covıd-19

South Korea suspends AstraZeneca COVID-19 shots for people under 60 amid European review

South Korea suspends AstraZeneca COVID-19 shots for people under 60 amid European review

7/4/2021 3:34:00 PM

South Korea suspends AstraZeneca COVID-19 shots for people under 60 amid European review

SEOUL: South Korea said on Wednesday (Apr 7) it will temporarily suspend providing AstraZeneca's COVID-19 vaccine to people below 60 amid a ...

Syringes filled with the AstraZeneca vaccine against COVID-19. (File photo: REUTERS/Essi Lehto)07 Apr 2021 08:06PMShare this contentBookmarkSEOUL: South Korea said on Wednesday (Apr 7) it will temporarily suspend providing AstraZeneca's COVID-19 vaccine to people below 60 amid a European review, while approving a Johnson & Johnson shot in a bid to speed up its inoculation roll-out.

Victoria JC student infected with Covid-19; 103 people quarantined, 2,200 others to be swabbed 7 community cases among 20 new COVID-19 infections in Singapore Victoria Junior College student positive for COVID-19; more than 100 students, staff members quarantined

The European Medical Agency (EMA) is due to announce the results of a review on whether some cases of blood clotting in adults may be linked to the AstraZeneca shot.AdvertisementAdvertisementThe announcement is due at 2pm GMT (10pm, Singapore time).Global controversy over the efficacy and side-effects of some COVID-19 vaccines has caused some delays in South Korea's vaccination campaign, which kicked off in late February with the goal of reaching herd immunity in November.

AstraZeneca has said previously its studies have found no higher risk of clots because of its vaccine, millions of doses of which have been administered worldwide. The World Health Organization and EMA have both said the benefits outweigh the risks.Advertisement headtopics.com

AdvertisementSouth Korea's food and drug safety ministry said on Wednesday it had granted final approval for Johnson & Johnson's (J&J) vaccine after a panel of experts ruled the single-dose shot was safe and effective.J&J is the third COVID-19 vaccine maker to be authorised in South Korea, after AstraZeneca and Pfizer-BioNTech, both of which require two doses.

Authorities are seeking to speed up a national vaccination campaign despite global supply shortages, while expanding preemptive testing and tracing efforts amid concerns over a potential fourth wave of infections.The Korea Disease Control and Prevention Agency (KDCA) reported

for Tuesday, the highest level since Jan 8, with clusters developing in kindergartens, saunas, bars and churches, mostly in the greater Seoul area.AdvertisementREAD: South Korea flags possible vaccine export curbs to secure COVID-19 shots"If the fourth wave of infections becomes a reality, a disruption to vaccination would be inevitable, as well as dealing a big blow to our economy," Prime Minister Chung Sye-kyun told a government meeting.

Health officials called on the public to refrain from non-essential gatherings and strictly log visits to crowded venues to help with epidemiological work in case of any outbreak.They also said they would announce new social distancing rules on Friday after discussion with experts and local governments. headtopics.com

Singapore to extend stay-home notice to 21 days for travellers from higher-risk places Malaysia sees more than 4,500 new COVID-19 cases; authorities say not planning nationwide MCO Many governments helping their country’s media; SPH case no different: Shanmugam Read more: CNA »

S'pore-HK air travel bubble starts May 26, 2 daily flights capped at 200 passengers each for first 2 weeks